Condition
Dupuytren Disease of Finger
Total Trials
4
Recruiting
2
Active
3
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Recruiting2
Active Not Recruiting1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04122313Recruiting
Post-contracture Release Radiation for Dupuytren's Disease
NCT07133945Not ApplicableCompletedPrimary
Can the Number of Skin Tears be Reduced, by Prophylactic Treatment of the Skin in Dupuytrens Contracture Treated With Collagenase?
NCT03406338Phase 4Active Not RecruitingPrimary
Fasciectomy vs Collagenase Injection in Recurrent Dupuytren Disease
NCT03797690Not ApplicableRecruitingPrimary
Effectiveness of Percutaneous Needle Aponeurotomy
Showing all 4 trials